España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Enveric Biosciences
ENVB
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.3250
-0.00340
-1.04%
At close: -
$0.3294
0.00440
1.35%
After Hours: 6:21 PM EDT
Get Report
Comment
Enveric Biosciences (ENVB) Forecast
News
Earnings
Enveric Biosciences (ENVB) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Enveric Biosciences (NASDAQ:ENVB) Stock
Enveric Biosciences Stock (NASDAQ: ENVB)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, December 02, 2024
Enveric Biosciences Announced That The United...
Benzinga Newsdesk
Wednesday, November 27, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Monday, November 25, 2024
Enveric Biosciences Advances Non-Hallucinogenic DMT Analog Drug With Promising Preclinical Results
Nina Zdinjak
Tuesday, November 19, 2024
Why Symbotic Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Monday, November 18, 2024
Enveric Biosciences Trims Losses, Eyes Key Drug Approval For Difficult-To-Treat Mental Health Disorders
Nina Zdinjak
Thursday, November 14, 2024
Enveric Biosciences Q3 2024 GAAP EPS $(0.24) ...
Benzinga Newsdesk
Tuesday, November 12, 2024
Enveric Biosciences Canada Granted U.S. Paten...
Benzinga Newsdesk
Enveric Biosciences Enters $62M Out-Licensing...
Benzinga Newsdesk
Enveric Biosciences Out-Licenses Key Program To MycoMedica In $62M Deal
Franca Quarneti
Monday, November 04, 2024
Enveric Biosciences Expands Patent Portfolio ...
Benzinga Newsdesk
Enveric Biosciences Expands Mental Health Patent Portfolio With 5 New Additions
Franca Quarneti
Wednesday, October 23, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Tuesday, October 15, 2024
Enveric Biosciences Advances Testing Of Its Non-Hallucinogenic Psychedelic
Juan Spínelli
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Enveric Biosciences Announces Pharmacology an...
Benzinga Newsdesk
Friday, October 04, 2024
Psychedelics 2.0: Companies Explore Safer, More Targeted Therapies
Juan Spínelli
Thursday, September 26, 2024
Enveric Biosciences Presents Data Highlightin...
Benzinga Newsdesk
Wednesday, September 25, 2024
Non-Hallucinogenic Psychedelic Treatment For Anxiety And Depression In Pre-Clinical Models: Enveric Biosciences' Breakthrough Research
Jelena Martinovic
Monday, September 23, 2024
'DEA Calls For Massive Increases In Psilocybi...
Benzinga Newsdesk
Tuesday, August 20, 2024
Enveric Biosciences Granted US Patent #120654...
Benzinga Newsdesk
Tuesday, August 13, 2024
Aries Science & Technology and Enveric Biosci...
Benzinga Newsdesk
Monday, August 12, 2024
Enveric Biosciences Q2 2024 GAAP EPS $(0.23) ...
Benzinga Newsdesk
Tuesday, July 30, 2024
Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Why F5 Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Thursday, July 25, 2024
Non-Hallucinogenic Psychedelic Treatment For Mental Health Disorders Shows Potential To Be Dosed Orally
Nina Zdinjak
Tuesday, July 16, 2024
'MDMA Therapy Gets Support From Prominent Res...
Benzinga Newsdesk
Monday, July 15, 2024
Aries Science & Technology And Enveric Biosci...
Benzinga Newsdesk
Thursday, July 11, 2024
New Patented Psychedelic Drug Brings Hope For Brain Disorder Therapies
Juan Spínelli
Wednesday, July 10, 2024
Enveric Biosciences Expands Protection For EB...
Benzinga Newsdesk
Tuesday, June 25, 2024
Enveric Biosciences Elevates EB-003 To Lead D...
Benzinga Newsdesk
Wednesday, June 12, 2024
'Oregon's First-In-Nation Psilocybin Industry...
Benzinga Newsdesk
Thursday, May 23, 2024
On May 21, Enveric Biosciences Received Lette...
Benzinga Newsdesk
Thursday, May 16, 2024
'Psychedelics-Inspired' Meds For Depression, Anxiety, Addiction Producer Trims Q1 Net Loss YoY, Increases Cash On Hand
Jelena Martinovic
Wednesday, May 15, 2024
Enveric Biosciences Q1 2024 GAAP EPS $(0.61) ...
Benzinga Newsdesk
Tuesday, May 14, 2024
Microdosing For Depression: Psychedelics Biotech Signs $66.5M Non-Binding Deal To Out-License Novel Psilocin Prodrug Candidate
Nina Zdinjak
Wednesday, May 08, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Cannabinoids With Chemotherapy For Breast Cancer: Psychedelics Biotech Inks $61M License Deal For Patented Methods
Nina Zdinjak
Tuesday, May 07, 2024
"FDA Expert Committee Will Review MDMA-Assist...
Benzinga Newsdesk
Wednesday, April 17, 2024
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
Lara Goldstein
Wednesday, April 03, 2024
Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Tuesday, April 02, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Friday, March 29, 2024
Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
Lara Goldstein
Wednesday, March 27, 2024
Enveric Biosciences Optimistic On Q4 And Full-Year Results: 'Psychedelic-Inspired' Meds For Future Growth
Lara Goldstein
Wednesday, March 20, 2024
Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
Lara Goldstein
Tuesday, March 19, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Enveric Biosciences Canada Granted U.S. Patent #11931338: Nitrilated psilocybin derivatives and methods of using
Charles Gross
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Nasdaq Down 100 Points; US Housing Starts Surge In February
Avi Kapoor
Why Is Anxiety/Addiction-Focused Enveric Biosciences Stock Trading Higher Tuesday?
Vandana Singh
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch